Evidence map›Paper›PMID 37178309›Full record

ArticleApplied microbiology and biotechnology2023

Efficient production of acetoin from lactate by engineered Escherichia coli whole-cell biocatalyst.

Zhenzhen Cui, Meiyu Zheng, Mengnan Ding, Wei Dai, Zhiwen Wang, Tao Chen

Abstract read
PubMed Publisher
In one paragraph

Article in Applied microbiology and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Multi-gene Co-expression systems inSynthetic and systems biotechnology · 2026
    Review
  2. Article
  3. Review
  4. Article
  5. Metabolic Engineering ofACS synthetic biology · 2025
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhenzhen CuiDepartment of Biochemical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Meiyu ZhengDepartment of Biochemical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Mengnan DingDepartment of Biochemical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Wei DaiDepartment of Biochemical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Zhiwen WangDepartment of Biochemical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Tao ChenDepartment of Biochemical Engineering, School of Chemical Engineering and Technology, Tianjin University, Tianjin, China. chentao@tju.edu.cn.ORCID http://orcid.org/0000-0001-9588-1821

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acetoin, an important and high-value added bio-based platform chemical, has been widely applied in fields of foods, cosmetics, chemical synthesis, and agriculture. Lactate is a significant intermediate short-chain carboxylate in the anaerobic breakdown of carbohydrates that comprise ~ 18% and ~ 70% in municipal wastewaters and some food processing wastewaters, respectively. In this work, a series of engineered Escherichia coli strains were constructed for efficient production of acetoin from cheaper and abundant lactate through heterogenous co-expression of fusion protein (α-acetolactate synthetase and α-acetolactate decarboxylase), lactate dehydrogenase and NADH oxidase, and blocking acetate synthesis pathways. After optimization of whole-cell bioconversion conditions, the engineered strain BL-11 produced 251.97 mM (22.20 g/L) acetoin with a yield of 0.434 mol/mol in shake flasks. Moreover, a titer of 648.97mM (57.18 g/L) acetoin was obtained in 30 h with a yield of 0.484 mol/mol lactic acid in a 1-L bioreactor. To the best of our knowledge, this is the first report on the production of acetoin from renewable lactate through whole-cell bioconversion with both high titer and yield, which demonstrates the economy and efficiency of acetoin production from lactate. Key Points • The lactate dehydrogenases from different organisms were expressed, purified, and assayed. • It is the first time that acetoin was produced from lactate by whole-cell biocatalysis. • The highest titer of 57.18 g/L acetoin was obtained with high theoretical yield in a 1-L bioreactor.

Indexed as

AcetoinLactic AcidBioreactorsEscherichia coliL-Lactate DehydrogenaseWastewaterAcetoinLactic AcidL-Lactate DehydrogenaseWastewaterAcetoinLactateLactate dehydrogenaseWhole-cell biocatalysisα-Acetolactate decarboxylaseα-Acetolactate synthetase

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.